Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Cancer. 2011 Mar 15;117(19):4390–4395. doi: 10.1002/cncr.26072

Table 4.

Molecular testing results for 228 cases of conventional papillary thyroid cancer

Group I (n=74) 1991–1995 Group II (n=103) 1996–2000 Group III (n=51) 2001–2005 P-value
Somatic mutation 68% (51/74) 64% (66/103) 92% (47/51) ≤ 0.002*
BRAF mutation 51% (38/74) 43% (44/103) 88% (45/51) <0.001*
RET/PTC1 0% 3% (3/103) 0% 0.15
RET/PTC3 14% (10/74) 16% (16/103) 4% (2/51) 0.18
NRAS 1% (1/74) 1% (1/103) 0% 0.44
KRAS 3% (2/74) 2% (2/103) 0% 0.52
*

For comparison of Group I and or II to Group III.